Billionaire Bill Ackman Hedge: Concentrated Bets in 3 Names
A hedge fund famous for bold bets shows a striking concentration: nearly half of its $14 billion stock portfolio sits...
A beginner-friendly intro to world stock dividend ETFs, covering basics like yields, diversification, and how to pick your first fund.
23,029 articlesA hedge fund famous for bold bets shows a striking concentration: nearly half of its $14 billion stock portfolio sits...
As investors parse Nano-X Imaging's Q4 2025 results, this guide breaks down the numbers, the business model, and what...
Teradyne spiked after Micron's strong results suggested AI-driven demand for memory and processing chips remains inta...
A patient investment fund quietly grabbed a multi-million stake in Masimo after a landmark deal. This article breaks ...
A real-world move shows an investment advisor trims small-cap exposure by millions, signaling risk management and str...
Two clinical-stage biotech names, two distinct paths to value. This guide breaks down Dyne Therapeutics and Viking Th...
Nebius inked a $27 billion AI infrastructure deal with Meta, locking in vast capacity and signaling its edge in the n...
A comprehensive, reader-friendly analysis of CVV's Q4 2025 earnings transcript. Learn how revenue trends, margins, an...
Public companies holding Bitcoin are rethinking financing moves as dilution costs start to bite. The era of easy gain...
Nio is signaling a major profitability milestone with its first adjusted profit, but the real impact for investors de...
A new study shows a troubling planning gap among executives with equity awards. Despite financial savvy, 44% lack a f...
Investors are watching Ambarella’s path to 2027 with a focus on growth drivers, margins, and the long-term AI camera ...